Company Valuation: Sanofi

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 1,11,194 1,12,665 1,12,549 1,16,968 1,00,655 87,736 - -
Change - 1.32% -0.1% 3.93% -13.95% -12.83% - -
Enterprise Value (EV) 1 1,21,177 1,19,102 1,20,342 1,25,740 1,11,663 99,998 98,134 97,427
Change - -1.71% 1.04% 4.49% -11.2% -10.45% -1.86% -0.72%
P/E ratio 17.8x 16.7x 20.8x 20.4x 12.9x 10.7x 9.92x 8.62x
PBR 1.62x 1.5x 1.52x 1.51x 1.41x 1.18x 1.12x 1.05x
PEG - 2.07x -1.1x 3.14x 0.3x 1.51x 1.31x 0.6x
Capitalization / Revenue 2.94x 2.62x 2.61x 2.85x 2.31x 1.88x 1.77x 1.69x
EV / Revenue 3.21x 2.77x 2.79x 3.06x 2.56x 2.14x 1.98x 1.87x
EV / EBITDA 9.95x 8.14x 8.44x 9.76x 8.22x 6.94x 6.44x 5.86x
EV / EBIT 11.3x 9.13x 9.5x 11.1x 9.19x 7.54x 7.02x 6.41x
EV / FCF 15x 14x 14.2x 21.1x 13.8x 11.6x 10.6x 9.33x
FCF Yield 6.68% 7.12% 7.04% 4.74% 7.24% 8.65% 9.43% 10.7%
Dividend per Share 2 3.33 3.56 3.76 3.92 4.12 4.288 4.523 4.821
Rate of return 3.76% 3.96% 4.19% 4.18% 4.98% 5.87% 6.19% 6.6%
EPS 2 4.97 5.37 4.31 4.59 6.4 6.852 7.372 8.481
Distribution rate 67% 66.3% 87.2% 85.4% 64.4% 62.6% 61.4% 56.8%
Net sales 1 37,761 42,997 43,070 41,081 43,626 46,717 49,576 52,049
EBITDA 1 12,183 14,627 14,259 12,889 13,583 14,418 15,249 16,633
EBIT 1 10,714 13,040 12,670 11,343 12,149 13,261 13,983 15,192
Net income 1 6,223 6,720 5,400 5,744 7,813 8,147 8,815 10,147
Net Debt 1 9,983 6,437 7,793 8,772 11,008 12,262 10,398 9,691
Reference price 2 88.58 89.84 89.76 93.74 82.72 73.10 73.10 73.10
Nbr of stocks (in thousands) 12,55,293 12,54,060 12,53,891 12,47,793 12,16,810 12,00,220 - -
Announcement Date 04/02/22 03/02/23 01/02/24 30/01/25 29/01/26 - - -
1EUR in Million2EUR
Estimates

P/E ratio, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
10.67x2.14x6.94x5.87% 10TCr
27.83x10.14x20.87x0.72% 85TCr
23.65x5.46x14.84x2.41% 53TCr
24.57x6.1x12.42x3.41% 36TCr
16.67x4.18x10.31x3.18% 32TCr
22.88x4.76x13.54x1.83% 28TCr
20.12x5.43x13.2x3.09% 28TCr
49.69x4.63x17.34x2.99% 28TCr
13.18x4.82x9.89x3.84% 20TCr
21.33x5.83x10.12x3.04% 18TCr
Average 23.06x 5.35x 12.95x 3.04% 33.79TCr
Weighted average by Cap. 24.74x 6.33x 14.83x 2.44%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield